Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at William Blair upped their FY2024 earnings estimates for Apellis Pharmaceuticals in a report issued on Tuesday ...
Investors in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 17, 2020 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback